Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Pilocarpine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for pilocarpine hydrochloride?

Pilocarpine hydrochloride is the generic ingredient in four branded drugs marketed by Lannett, Eisai Inc, Elan Pharma Intl Ltd, Impax Labs, Roxane, Novartis Pharms Corp, and Alcon, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for pilocarpine hydrochloride. Twelve suppliers are listed for this compound.

Summary for Generic Name: pilocarpine hydrochloride

Drug Master File Entries: see list12
Suppliers / Packagers: see list12
Bulk Api Vendors: see list34
Clinical Trials: see list996
Patent Applications: see list2,327
Therapeutic Class:Dental and Oral Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pilocarpine hydrochloride at DailyMed

Pharmacology for Ingredient: pilocarpine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs
pilocarpine hydrochloride
TABLET;ORAL077248-002Mar 31, 2006RXNoNo► Subscribe► Subscribe
pilocarpine hydrochloride
GEL;OPHTHALMIC018796-001Oct 1, 1984DISCNNoNo► Subscribe► Subscribe
Eisai Inc
pilocarpine hydrochloride
TABLET;ORAL020237-002Apr 18, 2003RXYesYes► Subscribe► Subscribe
Novartis Pharms Corp
pilocarpine hydrochloride
SOLUTION;OPHTHALMIC200890-003Jun 22, 2010RXYesYes► Subscribe► Subscribe
Eisai Inc
pilocarpine hydrochloride
TABLET;ORAL020237-001Mar 22, 1994RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.